<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2019</study_start_year><condition>Metastatic Colorectal Cancer</condition><disease>Metastatic Colorectal Cancer</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2614207</full_dataset_link><study_start_month>4</study_start_month><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>Tranexamic acid as initial treatment for unresectable metastatic colorectal cancer</name><description>Interventions: Off-label use
Primary outcome(s): Progression-free Survival:PFS
Study Design: randomized controlled trial, open(masking not used), active control, parallel assignment, treatment purpose</description><dates><creation>2019-04-15</creation></dates><accession>2614207</accession><cross_references><Japan Primary Registries Network>JPRN-jRCTs031180417</Japan Primary Registries Network></cross_references></HashMap>